![Søren Bregenholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Søren Bregenholt
Directeur Général chez
ALLIGATOR BIOSCIENCE AB
Profil
Søren Bregenholt currently works at Alligator Bioscience AB, as Chief Executive Officer from 2021, Medicon Valley Alliance FMBA, as Chairman, A Bioscience Incentive AB, as Chairman, Atlas Therapeutics AB, as Chairman, and Oblique Therapeutics AB, as Director.
Dr. Bregenholt also formerly worked at Macrophage Pharma Ltd., as Chief Executive Officer & Director, Novo Nordisk A, as Investment Manager, and Symphogen A, as Chief Operating Officer.
Dr. Bregenholt received his doctorate degree from the University of Copenhagen.
Dernières actualités sur Søren Bregenholt
Postes actifs de Søren Bregenholt
| Sociétés | Poste | Début |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Directeur Général | 01/06/2021 |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Président | - |
A Bioscience Incentive AB | Président | - |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Président | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Directeur/Membre du Conseil | - |
Anciens postes connus de Søren Bregenholt
| Sociétés | Poste | Fin |
|---|---|---|
| NOVO NORDISK A/S | Directeur en chef des Investissements | - |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur Général | - |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Directeur des opérations | - |
Formation de Søren Bregenholt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Medicon Valley Alliance FMBA
Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Commercial Services |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Health Technology |
A Bioscience Incentive AB | |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
